| Glioblastoma multiforme: Pathogenesis and treatment C Alifieris, DT Trafalis Pharmacology & therapeutics 152, 63-82, 2015 | 921 | 2015 |
| Targeting programmed cell death-1 (PD-1) and ligand (PD-L1): a new era in cancer active immunotherapy A Constantinidou, C Alifieris, DT Trafalis Pharmacology & therapeutics 194, 84-106, 2019 | 328 | 2019 |
| Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I. GD Geromichalos, CE Alifieris, EG Geromichalou, DT Trafalis https://www.jbuon.com/archive/21-4-764.pdf 21 (4), 764-779, 2016 | 48 | 2016 |
| Overview on the current status on virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part II. GD Geromichalos, CE Alifieris, EG Geromichalou, DT Trafalis http://www.jbuon.com/pdfs/1337-1358.pdf 21 (6), 1337-1358, 2016 | 48 | 2016 |
| Evidence for efficacy of treatment with the anti-PD-1 mab nivolumab in radiation and multichemorefractory advanced penile squamous cell carcinoma DT Trafalis, CE Alifieris, A Kalantzis, KE Verigos, C Vergadis, S Sauvage Journal of Immunotherapy 41 (6), 300-305, 2018 | 43 | 2018 |
| Breast cancer development in a female with Poland’s syndrome D Tamiolakis, I Venizelos, C Antoniou, N Tsiminikakis, E Alifieris, ... Oncology Research and Treatment 27 (6), 569-571, 2004 | 43 | 2004 |
| Papillary thyroid carcinoma metastasis most probably due to fine needle aspiration biopsy. A case report D Tamiolakis, C Antoniou, J Venizelos, M Lambropoulou, G Alexiadis, ... ACTA DERMATOVENEROLOGICA ALPINA PANONICA ET ADRIATICA 15 (4), 169, 2006 | 36 | 2006 |
| Phase II study of bevacizumab plus irinotecan on the treatment of relapsed resistant small cell lung cancer DT Trafalis, C Alifieris, GP Stathopoulos, N Sitaras Cancer chemotherapy and pharmacology 77, 713-722, 2016 | 32 | 2016 |
| Efficacy and safety of neoadjuvant treatment with bevacizumab, liposomal doxorubicin, cyclophosphamide and paclitaxel combination in locally/regionally advanced, HER2-negative … EC Tampaki, A Tampakis, CE Alifieris, D Krikelis, A Pazaiti, M Kontos, ... Clinical drug investigation 38, 639-648, 2018 | 31 | 2018 |
| Capecitabine, oxaliplatin, irinotecan, and bevacizumab combination followed by pazopanib plus capecitabine maintenance for high-grade gastrointestinal neuroendocrine carcinomas CE Alifieris, J Griniatsos, SG Delis, M Nikolaou, C Avgoustou, ... American Journal of Clinical Oncology 43 (5), 305-310, 2020 | 12 | 2020 |
| PI3K/AKT 通路通过 Nrf2 途径调控 PD-L1 在非小细胞肺癌中的表达 Targeting programmed cell death﹣ 1 (PD﹣ 1) and ligand (PD﹣ L1): a new era in cancer active immunotherapy A Constantinidou, C Alifieris, DT Trafalis, 王静 Pharmacol Ther 194 (84), 106, 2019 | 9 | 2019 |
| Topotecan and pegylated liposomal doxorubicin combination as palliative treatment in patients with pretreated advanced malignant pleural mesothelioma DT Trafalis, CS Alifieris, D Krikelis, N Tzogkas, GP Stathopoulos, ... International Journal of Clinical Pharmacologyand Therapeutics 50 (7), 490, 2012 | 8 | 2012 |
| Does parathyroidectomy affect residual diuresis in hemodialysis patients? I Tzanakis, E Alifieris, S Kagia, V Spantidakis, N Girousis, A Galis, ... Nephron 86 (3), 402-403, 2000 | 7 | 2000 |
| Ventriculoperitoneal shunting complicated with cerebrospinal fluid pseudocyst and acute appendicitis. A Krassoudakis, S Vlazakis, KN Kakavelakis, S Gardikis, G Sakellaris, ... Minerva pediatrica 54 (4), 321-323, 2002 | 5 | 2002 |
| The predictive value of 8-Hydroxy-Deoxyguanosine (8-OHdG) serum concentrations in irradiated non-small cell lung carcinoma (NSCLC) patients K Orfanakos, CE Alifieris, EK Verigos, MV Deligiorgi, KE Verigos, ... Biomedicines 12 (1), 134, 2024 | 4 | 2024 |
| Cytocidal antitumor effects against human ovarian cancer cells induced by B-lactam steroid alkylators with targeted activity against poly (ADP-Ribose) polymerase (PARP) enzymes … N Nikoleousakos, P Dalezis, A Polonifi, EG Geromichalou, S Sagredou, ... Biomedicines 9 (8), 1028, 2021 | 4 | 2021 |
| The arbitrary magic of p< 0.05: Beyond statistics CE Alifieris, E Souferi-Chronopoulou, DT Trafalis, A Arvelakis J BUON 25, 588-93, 2020 | 4 | 2020 |
| A retrospective open-label uncontrolled study of Epoetin zeta on the treatment of chemotherapy-induced anemia in solid tumors CE Alifieris, K Orfanakos, A Papanota, GP Stathopoulos, N Sitaras, ... Journal of cancer research and clinical oncology 143, 717-725, 2017 | 4 | 2017 |
| Indications for an alternative effective treatment of head and neck squamous cell carcinoma with temsirolimus plus bevacizumab: from bench to bedside? DT Trafalis, C Alifieris, P Dalezis, G Geromichalos, NM Sitaras Anti-cancer drugs 23 (8), 874-882, 2012 | 4 | 2012 |
| Fibroadenoma masquerading carcinoma on fine-needle aspiration of the breast D Tamiolakis Chirurgia, 2008 | 3 | 2008 |
Dimitrios TrafalisNational and Kapodistrian University of Athens, School of MedicineVerificeret mail på med.uoa.gr